In virus-independent liver lesions, atorvastatin use (10 mg/day) in NASH patients indicated an improvement in liver functions by 74%, along with a rise in serum protein and lipid metabolism regulator adiponectin (Hyogo et al., 2008
Furthermore, leaf metabolism seems to be very different from root metabolism
Orforglipron from Eli Lilly is a non-peptide, small-molecule GLP-1 agonist designed as a once-daily oral pill
Intravenous and intramuscular administration bypasses the digestive system, which metabolizes the substance and sends only a portion to cells
Declarations Acknowledgement We would like to acknowledge the leadership at the JSS Academy of Higher Education and Research for encouraging us to form the Special Interest Group on Human Genomics and Rare Disorders which motivated us to work on rare disorders
Are there other health benefits of GLP-1s